DEF: International Stem Cell Corporation Sets Date for Virtual Annual Stockholders Meeting
Proxy Statement
International Stem Cell Corporation announces its annual meeting of stockholders to be held virtually on June 17, 2025, covering director elections, executive compensation, and say-on-pay frequency.
Summary
- International Stem Cell Corporation will hold its annual meeting of stockholders virtually on June 17, 2025, at 10:00 a.m. Pacific Time.
- Stockholders of record as of April 22, 2025, are eligible to vote.
- The meeting will address the election of four directors, including two elected by Series D Preferred Stock holders.
- An advisory vote will be held on the compensation of named executive officers.
- Stockholders will also vote on the frequency of advisory votes on executive compensation.
- The board recommends voting for each director nominee and for the advisory vote on executive compensation, and for holding the advisory vote every three years.
- Stockholders can vote online, by phone, or by mail.
- The proxy materials are available online.
Sentiment
Score: 7
Explanation: The document is a routine proxy statement, so the sentiment is neutral to slightly positive due to the standard corporate governance processes being followed.
Positives
- The company is providing stockholders with multiple options for voting, including online, phone, and mail.
- The board is providing clear recommendations on how to vote on each proposal.
- The company is making proxy materials readily available online.
- The company encourages directors to attend the annual meeting.
Future Outlook
The company will review its activities over the past year and its plans for the future at the annual meeting.
Management Comments
- Andrey Semechkin, PhD, Chief Executive Officer and Co-Chairman: 'The Board of Directors and management look forward to your participation at the annual meeting.'
Industry Context
This announcement is a standard part of corporate governance, ensuring shareholders have a voice in key decisions.
Comparison to Industry Standards
- Holding an annual meeting is standard practice for publicly traded companies.
- Providing a virtual meeting option aligns with current trends in shareholder engagement.
- The proposals being voted on are typical for annual meetings, including director elections and executive compensation matters.
- The say-on-pay vote is a common practice following the Dodd-Frank Act.
Stakeholder Impact
- Shareholders have the opportunity to vote on key company matters.
- The outcome of the votes will influence the company's direction and governance.
Next Steps
- Stockholders should review the proxy materials and cast their votes.
- The company will hold the annual meeting on June 17, 2025.
- The company will file a Form 8-K report with the SEC within four business days of the Annual Meeting to report the final voting results.
Key Dates
| Date | Description |
|---|---|
| April 22, 2025 | Record date for stockholders eligible to vote at the Annual Meeting |
| June 13, 2025 | Deadline to register in advance to attend the virtual Annual Meeting |
| June 17, 2025 | Date of the Annual Meeting of Stockholders |
| January 7, 2026 | Deadline for stockholder proposals to be included in proxy materials for the 2026 annual meeting |
| February 17, 2026 | Earliest date for stockholder business that is not intended for inclusion in proxy materials to be brought before the annual meeting |
| March 19, 2026 | Latest date for stockholder business that is not intended for inclusion in proxy materials to be brought before the annual meeting |
Keywords
annual meeting, stockholders, proxy statement, directors, executive compensation, say on pay, voting, governance, International Stem Cell Corporation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.